Report: Cell technology, cell therapy, tissue engineering and gene therapy in Japan
This report is primarily concerned with developments, market trends and regulations within the Japanese cell technology, cell therapy, tissue engineering and gene therapy sectors.
Society has been late in digitisation, but the government tries to speed this up, among other things, to reduce the cost of health care. This is an excellent opportunity for EU companies with exciting solutions.
